[{"Assets_0_Q2_USD":452521000.0,"CommonStockSharesOutstanding_0_Q2_shares":116240963.0,"NetIncomeLoss_1_Q2_USD":-73864000.0,"NetIncomeLoss_2_Q2_USD":-106436000.0,"StockholdersEquity_0_Q2_USD":254371000.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]